These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38871090)

  • 21. Celastrol attenuates oxidative stress in the skeletal muscle of diabetic rats by regulating the AMPK-PGC1α-SIRT3 signaling pathway.
    Guan Y; Cui ZJ; Sun B; Han LP; Li CJ; Chen LM
    Int J Mol Med; 2016 May; 37(5):1229-38. PubMed ID: 27049825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice.
    Wang D; Luo Y; Wang X; Orlicky DJ; Myakala K; Yang P; Levi M
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29301371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic treatment with dapagliflozin protects against mitochondrial dysfunction in the liver of C57BL/6NCrl mice with high-fat diet/streptozotocin-induced diabetes mellitus.
    Belosludtsev KN; Starinets VS; Belosludtsev MN; Mikheeva IB; Dubinin MV; Belosludtseva NV
    Mitochondrion; 2021 Jul; 59():246-254. PubMed ID: 34144205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway.
    Yang X; Liu Q; Li Y; Tang Q; Wu T; Chen L; Pu S; Zhao Y; Zhang G; Huang C; Zhang J; Zhang Z; Huang Y; Zou M; Shi X; Jiang W; Wang R; He J
    Adipocyte; 2020 Dec; 9(1):484-494. PubMed ID: 32835596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Taurine Activates SIRT1/AMPK/FOXO1 Signaling Pathways to Favorably Regulate Lipid Metabolism in C57BL6 Obese Mice.
    Karikkakkavil Prakashan AD; Muthukumar SP; Martin A
    Mol Nutr Food Res; 2024 Apr; 68(8):e2200660. PubMed ID: 38549461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dynamic interplay between AMPK/NFκB signaling and NLRP3 is a new therapeutic target in inflammation: Emerging role of dapagliflozin in overcoming lipopolysaccharide-mediated lung injury.
    Abd El-Fattah EE; Saber S; Mourad AAE; El-Ahwany E; Amin NA; Cavalu S; Yahya G; Saad AS; Alsharidah M; Shata A; Sami HM; Kaddah MMY; Ghanim AMH
    Biomed Pharmacother; 2022 Mar; 147():112628. PubMed ID: 35032769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PGC1α deficiency reverses cholestasis-induced liver injury via attenuating hepatic inflammation and promoting bile duct remodeling.
    Li D; Ye C; Liu P; Sun T; Qin Y; Wan X
    Acta Histochem; 2023 Dec; 125(8):152097. PubMed ID: 37813066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Beneficial Effect of the SGLT2 Inhibitor Dapagliflozin in Alleviating Acute Myocardial Infarction-Induced Cardiomyocyte Injury by Increasing the Sirtuin Family SIRT1/SIRT3 and Cascade Signaling.
    Lin YH; Tsai WC; Chiu CC; Chi NY; Liu YH; Huang TC; Wu WT; Lin TH; Lai WT; Sheu SH; Hsu PC
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Dapagliflozin and Liraglutide on Diabetes-Induced Cardiomyopathy in Rats: Implication of Oxidative Stress, Inflammation, and Apoptosis.
    El-Shafey M; El-Agawy MSE; Eldosoky M; Ebrahim HA; Elsherbini DMA; El-Sherbiny M; Asseri SM; Elsherbiny NM
    Front Endocrinol (Lausanne); 2022; 13():862394. PubMed ID: 35370937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats.
    Durak A; Olgar Y; Degirmenci S; Akkus E; Tuncay E; Turan B
    Cardiovasc Diabetol; 2018 Nov; 17(1):144. PubMed ID: 30447687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AMPK-SIRT1-PGC1α Signal Pathway Influences the Cognitive Function of Aged Rats in Sevoflurane-Induced Anesthesia.
    Yang XY; Li QJ; Zhang WC; Zheng SQ; Qu ZJ; Xi Y; Wang G
    J Mol Neurosci; 2020 Dec; 70(12):2058-2067. PubMed ID: 32514740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice.
    Omori K; Nakamura A; Miyoshi H; Takahashi K; Kitao N; Nomoto H; Kameda H; Cho KY; Takagi R; Hatanaka KC; Terauchi Y; Atsumi T
    Metabolism; 2019 Sep; 98():27-36. PubMed ID: 31202833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dapagliflozin attenuates arrhythmic vulnerabilities by regulating connexin43 expression via the AMPK pathway in post-infarcted rat hearts.
    Lee CC; Chen WT; Chen SY; Lee TM
    Biochem Pharmacol; 2021 Oct; 192():114674. PubMed ID: 34252408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. lncRNA Oip5-as1 attenuates myocardial ischaemia/reperfusion injury by sponging miR-29a to activate the SIRT1/AMPK/PGC1α pathway.
    Niu X; Pu S; Ling C; Xu J; Wang J; Sun S; Yao Y; Zhang Z
    Cell Prolif; 2020 Jun; 53(6):e12818. PubMed ID: 32468629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dapagliflozin not only improves hepatic injury and pancreatic endoplasmic reticulum stress, but also induces hepatic gluconeogenic enzymes expression in obese rats.
    Swe MT; Thongnak L; Jaikumkao K; Pongchaidecha A; Chatsudthipong V; Lungkaphin A
    Clin Sci (Lond); 2019 Dec; 133(23):2415-2430. PubMed ID: 31769484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blunting p38 MAPKα and ERK1/2 activities by empagliflozin enhances the antifibrotic effect of metformin and augments its AMPK-induced NF-κB inactivation in mice intoxicated with carbon tetrachloride.
    Abdelhamid AM; Youssef ME; Abd El-Fattah EE; Gobba NA; Gaafar AGA; Girgis S; Shata A; Hafez AM; El-Ahwany E; Amin NA; Shahien MA; Abd-Eldayem MA; Abou-Elrous M; Saber S
    Life Sci; 2021 Dec; 286():120070. PubMed ID: 34688695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Empagliflozin ameliorates liver fibrosis in NASH rat model via targeting hepatic NF-κB/SOX9/OPN signaling and osteocalcin level.
    Elseweidy MM; Ali AE; Hassanin SM; Mahmoud YK
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3449-3459. PubMed ID: 37962587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dapagliflozin Attenuates Na
    Ye Y; Jia X; Bajaj M; Birnbaum Y
    Cardiovasc Drugs Ther; 2018 Dec; 32(6):553-558. PubMed ID: 30367338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dapagliflozin Ameliorates STZ-Induced Cardiac Hypertrophy in Type 2 Diabetic Rats by Inhibiting the Calpain-1 Expression and Nuclear Transfer of NF-
    Liu L; Luo H; Liang Y; Tang J; Shu Y
    Comput Math Methods Med; 2022; 2022():3293054. PubMed ID: 35096128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Sodium-Glucose Cotransporter-2 during Serum Deprivation Increases Hepatic Gluconeogenesis via the AMPK/AKT/FOXO Signaling Pathway.
    Lee J; Hong SW; Kim MJ; Lim YM; Moon SJ; Kwon H; Park SE; Rhee EJ; Lee WY
    Endocrinol Metab (Seoul); 2024 Feb; 39(1):98-108. PubMed ID: 38171209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.